Delivery Order SPE2DB22D2206-SPE2DB25FHV92

Award Date 7/11/25
Potential Completion Date 8/1/25
Potential Value $28K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,920.91, is for the delivery of ORSERDU 345 MG TABLET 30S, a pharmaceutical product, with a completion date of June 30, 2025. The contract is not set-aside and was awarded on June 6, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
This is a $13,920.91 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ORSERDU 345 MG TABLET 30S, a pharmaceutical product, with a period of performance through June 3, 2025. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ORSERDU 345 MG TABLET 30S, with a ceiling value of $13,920.91 and a completion date of July 7, 2025. The contract is a firm fixed-price, non-set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued...
This federal contract award is for the delivery of ORSERDU 345 MG TABLET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $26,927.56 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 22, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $27,841.82 and is for the delivery of ORSERDU 345 MG TABLET 30S, a medical supply item. The contract is not set aside and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp. The contract is for the delivery of ORSERDU 345 MG TABLET 30S, a pharmaceutical product, with a total ceiling value of $40,391.31. The contract has a firm fixed price pricing type and an ultimate completion date of October 16, 2024. The contract was awarded on September 24, 2024, and there is no set-aside designation. AmerisourceBergen Drug Corp, a major...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ORSERDU 345 MG TABLET 30S, with a ceiling value of $27,841.82 and a performance period ending on June 18, 2025. The contract is a firm fixed-price delivery order and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,920.91 firm fixed-price delivery order contract is for the supply of ORSERDU 345 MG TABLET 30S, which are likely pharmaceutical products. The contract has an ultimate completion date of January 24, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $13,463.77 contract is for the supply of ORSERDU 345 MG TABLET 30S, a pharmaceutical product, with a completion date of March 22, 2024. The award is not associated with any set-aside designation. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ORSERDU 345 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $41,762.73 and a period of performance through July 21, 2025. The contract is a firm fixed-price delivery order, without a set-aside designation, indicating open competition. Amerisourcebergen Drug...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FHV92
    Delivery Order

This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $27,841.82 firm fixed-price contract is for the delivery of ORSERDU 345 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of August 1, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor and holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026 to supply a wide range of pharmaceutical products and medical supplies to military healthcare programs and other government agencies.

Generated 10/12/25, 12:59 AM